Clinical Experience With Antibiotic Protocol & RSD N=22 Duration of treatment: 2-4 months Retrospective, open label, clinical trial Responses are based.

Slides:

Advertisements

Similar presentations

Patient enrollment DIAS-4 vs. Endovascular Therapy

Advertisements

Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.

One good example of considering gene expressions at the review for approval Taxol: Indicated for the adjuvant treatment of node- positive breast cancer.

A Randomized Trial Comparing Interventions in Patients with Lumber Posterior Derangement. Author: Schenk. Journal of Manual & Manipulative Therapy, Volume.

Adverse events in an integrated, home-based treatment program for MDR-TB & HIV in Tugela Ferry, South Africa JCM Brust*, NS Shah, TL van der Merwe, S Bamber,

Predicting Subsequent Response to Hormone Therapy Following First-line Androgen Deprivation in Advanced Prostate Cancer S. Turner H. Gurney V. Gebski M.

The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.

The SToP-BPD study Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants Clinical lesson Oct 2011.

TULSA BONE & JOINT ANTOINE (TONY) JABBOUR, MD ORTHOPAEDIC SPORTS MEDICINE SURGEON KNEE AND SHOULDER SUBSPECIALTY CHAPTER 20 PAIN SYNDROMES CHAPTER 21 NERVE.

Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.

1 Markham C. Luke, M.D., Ph.D. Dermatology Clinical Team Leader DDDDP, ODE V, CDER, FDA Combination Topical Products for the Treatment of Acne Vulgaris.

Antibiotics I.. Consequences of inappropriate antibiotic therapy Inappropriate antibiotic therapy can lead to increases in:Inappropriate antibiotic therapy.

Caroline Roche SCIENCE RESEARCH ARTICLES.  Why should we care?  Nearly 90% of people get a headache at least once in their lifetime  Headaches can.

Responses to Subsequent Anti-HER2 Therapy After Treatment with Trastuzumab-DM1 in Women with HER2- Positive Metastatic Breast Cancer 1 A Phase Ib/II Trial.

Clinical Trials 2015 Practical Session 2. Exercise I Normally Distributed Response Data H 0 :  = 0 H a :  =  a > 0 n=? α=0.05 (two-sided) β=0.20 

R1 김동연 /prof. 이창균. Introduction  Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high.

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Aron Goldhirsch, Richard.

Amoxicillin for Acute Rhinosinusitis A Randomized Controlled Trial Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. JAMA 2012;307(7): Prof.

A Marked Decrease in Serum Cortisol and Histamine Levels Using the Lumen Therapeutic Protocols for Acute Low Back Pain By Stan Gross, D.C., F.A.S.A.

VALDEZ ET AL CLINICAL INFECTIOUS DISEASES 2011;52(6):726–735 R2 Kim Dong Hyun Decreased Infection-Related Mortality & Improved Survival in Severe Aplastic.

COMPARATIVE STUDY OF ORMELOXIFENE AND MEDROXYPROGESTERENE ACETATE IN ABNORMAL UTERINE BLEEDING.

Medical Directorate, National Kidney Foundation, Singapore

THE USE OF A WRITTEN ASTHMA ACTION PLAN IN PATIENTS DISCHARGED FROM THE EMERGENCY DEPARTMENT OF THE MATER MISERICORDIAE UNIVERSITY HOSPITAL Dr. Nafisah.

ABSTRACT Problem Statement: The universal coverage policy (UCP) and 30 Baht Scheme was launched in Thailand in February, Since then, the National.

Canagliflozin: Real World Experience

Best physiotherapy Centre in Hyderabad Best physiotherapy Centre in Hyderabad.

The Nurse View.

Pseudomonas Infection in Cystic Fibrosis

Clinical Trials in IBD.

This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.

Progression After Cancer Immunotherapy in Advanced NSCLC

Kantarjian H et al. Cancer 2009;[Epub ahead of print].

Metastatic Renal Cell Carcinoma

Neurostimulation for the Management of Medication-Resistant Epilepsy

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

Oral Vancomycin as a Therapeutic Option for PSC

Clinical results of arthroscopic release or open release

Clinical Considerations in Evidence-based Management of GIST

A Case Challenge: Anticoagulant Choices for Acute PE

Krop I et al. SABCS 2009;Abstract 5090.

Acute Pulmonary Exacerbations of Sarcoidosis

Opportunities and Challenges in the Management of Advanced STS

FAIR Trial design: Patients with SFA in-stent restenosis (ISR) were randomized to either a paclitaxel-coated balloon (DCB) (dose 3.5 μg/mm2) or routine.

EHL Technologies in Hemophilia Care

Label Name Label Name Label Name Label Name Label Name Label Name

Preventing Clinical Events in PAH

Trials and Tribulations in VTE: How Do Real-World Data Fit In?

When Is Intrathecal Drug Delivery Appropriate?

Anaerobic threshold responder analysis

Add-On Therapy to Insulin in T1DM Management

There is significant unexplained inter-cycle variation in ovarian performance during IVF treatment Thanos Papathanasiou, Nausheen Mawal, Phil Snell. Bourn.

J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan

The Research Question Background: Question:

Main inclusion criteria)

When Is Intrathecal Drug Delivery Appropriate?

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

Mean change from baseline for perceived cognitive impairments (A), cognitive functioning (B), usual level of fatigue (C) and fatigue interference (D) at.

Clinical Considerations in Evidence-based Management of GIST

The Research Question Lateral epicondylosis (tennis elbow) is common, debilitating and often refractory to routine care. Prolotherapy, an injection-based.

Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study A. Doi, T.

Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Patient education with or without manual therapy compared to a control group in patients with osteoarthritis of the hip. A proof-of-principle three-arm.

My PAH Patient.

Yoga treatment for chronic non-specific low back pain

Presentation transcript:

Clinical Experience With Antibiotic Protocol & RSD N=22 Duration of treatment: 2-4 months Retrospective, open label, clinical trial Responses are based on patient perceived outcomes

A.P. Lab Results In RSD Patients* *12 patients had more then one abnormality Number of patients

Exacerbations of Pain & Fatigue At 1-4 Months Of Treatment Number of patients *Increase in pain by 20-80% **Increase in fatigue by %

Decrease In Pain, Fatigue & Dystrophic Findings (At 2-4 Months Of Treatment) Number of patients *Dec. Pain at % **Dec. Fatigue at 25-50% ***Dec. Dystrophy at 25-75% Note: Only 1 of 2 of the “No effect” patients has completed 4 months of A.P. therapy. All “No Effect” patients continue to report increased pain or fatigue from treatment.

Conclusions Antibiotic protocol can offer substantial improvement in at least some patients with RSD. It remains speculation as to which RSD cases will respond to A.P.

(864)